---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-020222"
form_type: "8-K"
ticker: "CPIX"
cik: "0001087294"
company_name: "CUMBERLAND PHARMACEUTICALS INC"
filed_at: "2025-04-28T23:59:59+00:00"
generated_at: "2026-05-23T04:42:38.232513+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Cumberland shareholders re-elect three directors, ratify auditor with >98% votes

## Summary
- Directors Bernard, Galante, and Kazimi re-elected with 98.6%, 99.2%, and 99.6% votes in favor.
- Auditor Carr, Riggs & Ingram ratified for 2025 with 99.7% votes in favor.
- Annual meeting held April 22, 2025 in Nashville, Tennessee.

## SEC filing metadata
- accession: 0001628280-25-020222
- form_type: 8-K
- ticker: CPIX
- cik: 0001087294
- company_name: CUMBERLAND PHARMACEUTICALS INC
- filed_at: 2025-04-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1087294/000162828025020222/0001628280-25-020222-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1087294/000162828025020222/cpix-20250428.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-020222
- JSON: https://secwatch.observer/filing/0001628280-25-020222.json
- Plain text: https://secwatch.observer/filing/0001628280-25-020222.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.